June 2020

Home  /  2020

EUnetHTA deems patient involvement very important in the production of Joint/Collaborative Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We

The final project plan of the relative effectiveness assessment of ‘Glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction

​The final report ‘Recommendations for Horizon Scanning, Topic Identification, Selection and Prioritisation for European Cooperation on Health Technology Assessment’ is now available. The draft recommendations were under consultation during the period July–September 2018. An overview and response to the feedback during